Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

The potential of LAS-IPA (target substance) to induce skin irritation/corrosion was evaluated in two suitable in vitro test methods (OECD 439 and OECD 431). The results show that the substance is not corrosive to the skin, but it does have irritating properties. Based on the results, the target substance can be considered as irritant to the skin. Therefore, classification as Skin Irrit. 2, H315 is warranted in accordance with the CLP criteria.

The potential of the target substance to induce eye irritation was assessed using data from a suitable in vitro eye irritation test. Based on the results, the target substance can be considered as irritant to the eye. Therefore, classification as Eye Irrit.2, H319 is warranted in accordance with the CLP criteria.

Key value for chemical safety assessment

Skin irritation / corrosion

Link to relevant study records

Referenceopen allclose all

Endpoint:
skin irritation: in vitro / ex vivo
Type of information:
experimental study
Adequacy of study:
weight of evidence
Study period:
Unavailable - study report dated 2012
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study
Qualifier:
according to guideline
Guideline:
OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
Deviations:
no
Qualifier:
according to guideline
Guideline:
EU Method B.46 (In Vitro Skin Irritation: Reconstructed Human Epidermis Model Test)
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Test system:
human skin model
Source species:
human
Cell type:
non-transformed keratinocytes
Vehicle:
unchanged (no vehicle)
Details on test system:
Three-dimensional reconstructed human epidermis- EPISKIN model kit purchased from SkinEthic Laboratories (Lyon, France).
Control samples:
yes, concurrent negative control
yes, concurrent positive control
Amount/concentration applied:
TEST MATERIAL
- Amount applied: 10 µL

NEGATIVE CONTROL
- Amount applied: 10 µL DPBS

POSITIVE CONTROL
- Amount applied: 10 µL 5% w/v SDS
Duration of treatment / exposure:
15 min
Duration of post-treatment incubation (if applicable):
42 hours
Number of replicates:
not specified
Details on study design:
Test MTT reduction by the test material: 10 µL test material + 2 mL 0.3 mg/mL MTT solution incubated for 3 h. The blue colour indicates reduced MTT.

MAIN TEST
DAY 1-Application of test item
Exposure: 15 min
Amount applied: 10 µL
Negative control: 10 µL DPBS
Positive control: 10 µL 5% w/v SDS
Washing: DPBS with Ca++ and Mg++
Post-exposure incubation: 42 h

DAY 3-MTT Loading/Formazan Extraction
Plate shaker: 15 min
MTT solution: 2 mL of 0.3 mg/mL per well
Incubation: 3 h
Biopsy of the epidermis was performed. The tissue was then transfered in micro tubes with 500 µL acidified isopropanol and refrigerated till day 6.

DAY 6-Absorbance/Optical Density
at 540 nm with Anthos 2001 microplate reader

Irritation / corrosion parameter:
% tissue viability
Remarks:
Relative Mean Viability
Value:
6.8
Vehicle controls validity:
valid
Negative controls validity:
valid
Positive controls validity:
valid
Remarks on result:
other:
Remarks:
See below for detailed results.
Other effects / acceptance of results:
- OTHER EFFECTS:
The MTT solution conatining the test item did not turn blue, suggesting that the test material does not reduce directly MTT.

- ACCEPTANCE OF RESULTS:
Acceptance criteria met for negative and positive controls.

Table 1: Mean OD540 values and percentage viabilities for the negative control Item, positive control Item and test item

Item

OD540 of

tissues

Mean OD540

of triplicate

tissues

± SD of

OD540

Relative

individual

tissue

viability (%)

Relative

mean

viability (%)

± SD of

Relative

mean

viability (%)

Negative

Control Item

0.786

0.753

0.029

104.4

100

3.8

0.737

97.9

0.735

97.6

Positive

Control Item

0.129

0.110

0.039

17.1

14.6

5.2

0.065

8.6

0.136

18.1

Test Item

0.032

0.051

0.017

4.2

6.8

2.3

0.055

7.3

0.066

8.8

 

Interpretation of results:
Category 2 (irritant) based on GHS criteria
Conclusions:
Under the conditions of this in vitro test benzenesulfonic acid, 4-C10-13-sec-alkyl derivs.-, compd. with 2-propanamine (1:1) is irritating to the skin.
Executive summary:

In a primary dermal irritation study conducted according to OECD Guideline for the Testing of Chemicals No. 439 “In Vitro Skin Irritation” (adopted 22 July 2010), EPISKIN™ reconstructed human epidermis model was topically exposed to 10 µL of undiluted benzenesulfonic acid, 4-C10-13-sec-alkyl derivs.-, compd. with 2 -propanamine (97% purity) for 15 min and 42 h post incubation period. The principle of the assay was based on the measurement of cytotoxicity in the human epidermal cultures following topical exposure to the test item, with the MTT reduction assay. The negative and positive controls confirmed the validity of the study.

The test item is irritating to the skin. The relative mean tissue viability was ≤ 50% (6.8%) after 15 min treatment and 42 h post-incubation. Based on the results, benzenesulfonic acid, 4-C10-13-sec-alkyl derivs.-, compd. with 2-propanamine is classified to be irritating to the skin in accordance with UN GHS "Category 2".

The study is considered acceptable based on the quality criteria.

Endpoint:
skin corrosion: in vitro / ex vivo
Type of information:
experimental study
Adequacy of study:
weight of evidence
Study period:
Unavailable - study report dated 2013
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study
Qualifier:
according to guideline
Guideline:
OECD Guideline 431 (In Vitro Skin Corrosion: Human Skin Model Test)
Deviations:
no
Qualifier:
according to guideline
Guideline:
EU Method B.40 (In Vitro Skin Corrosion: Transcutaneous Electrical Resistance Test (TER))
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Test system:
human skin model
Source species:
human
Cell type:
non-transformed keratinocytes
Vehicle:
unchanged (no vehicle)
Control samples:
yes, concurrent negative control
yes, concurrent positive control
Amount/concentration applied:
TEST MATERIAL
- Amount applied: 50 µL

NEGATIVE CONTROL
- Amount applied: 50 µL of 0.9% w/v sodium chloride

POSITIVE CONTROL
- Amount applied: 50 µL glacial acetic acid
Duration of treatment / exposure:
3, 60 and 240 min
Number of replicates:
At least 2 per exposure time
Details on study design:
Pre-test: Test MTT reduction by the test material: 50 µL test material + 2.2 ml 0.3 mg/mL MTT solution incubated for 3 h. The blue colour indicates reduced MTT.

MAIN TEST
DAY 1-Application of test item
Exposure: 3, 60 and 240 min
Amount applied: 50 µL
Negative control: 50 µL of 0.9% w/v sodium chloride
Positive control: 50 µL glacial acetic acid
Washing: PBS with Ca++ and Mg++
MTT solution was applied: 2.2 mL of 0.3 mg/mL per well, incubation followed for 3 h ± 5 min
Biopsy of the epidermis was performed. The tissue was then transfered in micro tubes with 850 µL acidified isopropanol.

DAY 2-Absorbance/Optical Density
at 540 nm with Anthos 2001 microplate reader
Irritation / corrosion parameter:
% tissue viability
Run / experiment:
3 min
Value:
77.5
Vehicle controls validity:
not applicable
Negative controls validity:
valid
Positive controls validity:
valid
Remarks on result:
no indication of irritation
Irritation / corrosion parameter:
% tissue viability
Run / experiment:
60 min
Value:
90.5
Vehicle controls validity:
not applicable
Negative controls validity:
valid
Positive controls validity:
valid
Remarks on result:
no indication of irritation
Irritation / corrosion parameter:
% tissue viability
Run / experiment:
240 min
Value:
85.2
Vehicle controls validity:
not applicable
Negative controls validity:
valid
Positive controls validity:
valid
Remarks on result:
no indication of irritation
Other effects / acceptance of results:
- OTHER EFFECTS:
The MTT solution containing the test item did not turn blue, suggesting that the test material does not reduce directly MTT

- ACCEPTANCE OF RESULTS:
Acceptance criteria met for negative and positive controls.

Table 1: Mean OD540 values and viabilities for the negative control item, positive control item and test item

Item

Exposure period

Mean OD540 of

duplicate tissues

Relative mean

viability (%)

Negative control

240 min

0.169

100

Positive control

240 min

0.024

14.2

Test item

240 min

0.144

85.2

60 min

0.153

90.5

3 min

0.131

77.5

Interpretation of results:
GHS criteria not met
Conclusions:
Under the conditions of this in vitro test benzenesulfonic acid, 4-C10-13-sec-alkyl derivs.-, compd. with 2-propanamine (1:1), is not corosive to the skin.
Executive summary:

In a primary skin corrosion study conducted according to the OECD Guideline for the Testing of Chemicals No. 431 “In VitroSkin Corrosion” (adopted April 2004), the EPISKIN™ reconstructed human epidermis model was exposed to 50 µL of undiluted benzenesulfonic acid, 4-C10-13-sec-alkyl derivs.-, compd. with 2-propanamine (97% purity) for 3, 60, and 240 minutes. The principle of the assay was based on the measurement of cytotoxicity in the human epidermal cultures following topical exposure to the test item, with the MTT reduction assay. The negative and positive controls confirmed the validity of the study.

The test item showed no corrosive effects. The relative mean tissue viability was greater than 15% (90.5%) after 60 min treatment and greater than 50% (77.5%) after 3 min treatment. In addition, the relative mean viability of the test item treated tissues was 85.2% after 240 min treatment. Based on the results, benzenesulfonic acid, 4-C10-13-sec-alkyl derivs.-, compd. with 2-propanamine is classified as “non-corrosive“ in accordance with the UN GHS classification system.

The study is considered acceptable based on the quality criteria.

Endpoint conclusion
Endpoint conclusion:
adverse effect observed (irritating)

Eye irritation

Link to relevant study records
Reference
Endpoint:
eye irritation: in vitro / ex vivo
Type of information:
experimental study
Adequacy of study:
weight of evidence
Study period:
2012-10-16 to 2013-01-15
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
study well documented, meets generally accepted scientific principles, acceptable for assessment
Qualifier:
no guideline followed
Principles of method if other than guideline:
The test is based on the hypothesis that irritant chemicals are able to penetrate the corneal epithelial tissue and are sufficiently cytotoxic to cause cell death. Cytotoxicity is measured with the MTT reduction assay.
GLP compliance:
yes (incl. QA statement)
Details on test animals or tissues and environmental conditions:
SkinEthic reconstructed Human Corneal Epithelium model (HCE, SkinEthic Laboratories, Lyon, France)
Vehicle:
unchanged (no vehicle)
Controls:
yes, concurrent positive control
yes, concurrent negative control
Amount / concentration applied:
TEST MATERIAL
- Amount applied: 30 µL
Duration of treatment / exposure:
10 min
Number of animals or in vitro replicates:
2
Details on study design:
Pre-test: Test MTT reduction by the test material: 30 µL test material + 1 mL 0.5 mg/mL MTT solution incubated for 3 h. The blue colour indicates reduced MTT.

MAIN TEST
7-day old tissues were transferred into wells and treated with 30 µL test item
Exposure period: 10 min
Negative control: 30 µL solution A
Positive control: 30 µL of 2% w/v SDS
Washing: DPBS without Ca++ and Mg++
Placement of each tissue into a 24-well plate with 300 µl maintenance medium
MTT loading plates: 300 µL of a 0.5 mg/mL MTT solution
Incubation: 3 hours
Washing: phosphate buffered saline
Isopropanol was applied for the formation of formazan crystals
Optical density (OD) was measured at 540 nm with Anthos 2001 microplate reader

Tissue histopathology: one tissue/treatment group was kept for histopathological examination
Irritation parameter:
other: OD at 540 nm
Run / experiment:
1
Value:
ca. 0.141
Vehicle controls validity:
not applicable
Negative controls validity:
valid
Positive controls validity:
valid
Remarks on result:
positive indication of irritation
Irritation parameter:
other: OD at 540 nm
Run / experiment:
2
Value:
ca. 0.167
Vehicle controls validity:
not applicable
Negative controls validity:
valid
Positive controls validity:
valid
Remarks on result:
positive indication of irritation
Irritation parameter:
other: mean percent tissue viability  (migrated information)
Run / experiment:
mean of 2 tissues
Value:
ca. 16.6
Vehicle controls validity:
not applicable
Negative controls validity:
valid
Positive controls validity:
valid
Remarks on result:
positive indication of irritation

Table 1: Assessment of Eye Irritation Potential- Viability of HCE tissues

Item

OD540of Individual Tissue

Mean OD540

Relative Mean Viability (%)

Negative Control

0.965

0.926

100

0.887

Positive Control

0.022

0.022

2.4

0.021

Test item

0.141

0.154

16.6

0.167

 

Tissue histopathological examination was not performed because it was not considered necessary.

Interpretation of results:
Category 2 (irritating to eyes) based on GHS criteria
Conclusions:
Based on the results of the study, BIO-SOFT 411-E and hence, benzenesulfonic acid, 4-C10-13-sec-alkyl derivs.-, compd. with 2-propanamine (1:1), are both eye irritants.
Executive summary:

In anin vitro eye irritation study, 30 µL of BIO-SOFT 411-E and hence, benzenesulfonic acid, 4-C10-13-sec-alkyl derivs.-, compd. with 2-propanamine (1:1) (97% purity) was applied in the SkinEthic reconstructed Human Corneal Epithelium model (HCE, SkinEthic Laboratories, Lyon, France) for a treatment period of 10 minutes. The test is based on the hypothesis that irritant chemicals are able to penetrate the corneal epithelial tissue and are sufficiently cytotoxic to cause cell death. Cytotoxicity was measured with the MTT reduction assay.

Triplicate tissues were exposed to the test material and thereafter, to MTT. The optical density was measured at 540 nm. Data were presented in the form of percentage viability (MTT conversion relative to negative controls). The controls confirmed the validity of the study.

The test item showed irritant effects. The mean relative tissue viability of the three replicates was < 60% (16.6% ). Therefore, the test item is considered to be irritating to the eyes in accordance with UN GHS “Category 2”.

Endpoint conclusion
Endpoint conclusion:
adverse effect observed (irritating)

Respiratory irritation

Endpoint conclusion
Endpoint conclusion:
no study available

Additional information

The potential skin effects of benzenesulfonic acid, 4-C10-13-sec-alkyl derivs.-, compd. with 2-propanamine (97%) were tested in two in vitro studies with the use of reconstructed human epidermis models (EPISKINTM). The principle of the assays is based on the measurement of cytotoxicity in the human epidermal cultures following topical exposure to the test material, with the MTT reduction assay. The in vitro test for skin corrosion gave a negative result, while the in vitro test for skin irritation indicates that the substance has skin irritating properties.

An in vitro eye irritation test was performed with the use of the SkinEthic Human Corneal Epithelium model in order to examine the eye irritation potential of benzenesulfonic acid, 4-C10-13-sec-alkyl derivs.-, compd. with 2-propanamine (97%). The results showed a relative mean viability of the test item treated tissues after a 10 min exposure period of 16.6 %, i.e. the test item shall be considered an eye irritant.


Justification for classification or non-classification

Based on the classification criteria laid down in Regulation (EC) No 1272/2008 benzenesulfonic acid, 4-C10-13-sec-alkyl derivs.-, compd. with 2-propanamine (LAS IPA) shall be classified and labelled as irritating to the skin (Skin Irrit. 2, H315) and eye (Eye Irrit. 2, H319).